BioRestorative Therapies, Inc.
BRTX
$1.71
$0.021.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -81.46% | 162.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -81.46% | 162.18% | |||
| Cost of Revenue | -81.87% | 180.00% | |||
| Gross Profit | -81.43% | 160.77% | |||
| SG&A Expenses | -9.34% | -6.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.44% | -1.46% | |||
| Operating Income | -17.63% | 7.36% | |||
| Income Before Tax | -49.91% | 72.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -49.91% | 72.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -49.91% | 72.91% | |||
| EBIT | -17.63% | 7.36% | |||
| EBITDA | -17.92% | 7.53% | |||
| EPS Basic | -49.85% | 72.90% | |||
| Normalized Basic EPS | 106.90% | 72.90% | |||
| EPS Diluted | -50.30% | 73.12% | |||
| Normalized Diluted EPS | 106.90% | 72.90% | |||
| Average Basic Shares Outstanding | 0.05% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||